アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/02/14 | 1,661.5 | 1,669.5 | 1,646.5 | 1,666 | +11 | +0.7% | 7,484,700 |
2024/02/13 | 1,623 | 1,655 | 1,618 | 1,655 | +39.5 | +2.4% | 10,742,300 |
2024/02/09 | 1,597 | 1,621.5 | 1,594 | 1,615.5 | +5.5 | +0.3% | 9,391,000 |
2024/02/08 | 1,610 | 1,619.5 | 1,591 | 1,610 | -11.5 | -0.7% | 15,869,200 |
2024/02/07 | 1,606 | 1,629 | 1,605 | 1,621.5 | -1.5 | -0.1% | 11,396,000 |
2024/02/06 | 1,662 | 1,699.5 | 1,623 | 1,623 | -77 | -4.5% | 24,370,600 |
2024/02/05 | 1,680 | 1,703 | 1,668 | 1,700 | +20 | +1.2% | 9,320,200 |
2024/02/02 | 1,699.5 | 1,703 | 1,680 | 1,680 | -12 | -0.7% | 7,148,500 |
2024/02/01 | 1,705 | 1,712.5 | 1,680.5 | 1,692 | -33 | -1.9% | 9,933,200 |
2024/01/31 | 1,711 | 1,729.5 | 1,706 | 1,725 | +12 | +0.7% | 6,895,500 |
2024/01/30 | 1,714 | 1,730.5 | 1,713 | 1,713 | +0.5 | ±0% | 4,680,300 |
2024/01/29 | 1,698 | 1,721.5 | 1,698 | 1,712.5 | +24.5 | +1.5% | 6,089,500 |
2024/01/26 | 1,693.5 | 1,695 | 1,676 | 1,688 | -13 | -0.8% | 7,662,700 |
2024/01/25 | 1,700 | 1,707.5 | 1,682.5 | 1,701 | -2 | -0.1% | 8,092,400 |
2024/01/24 | 1,711.5 | 1,718 | 1,702 | 1,703 | -21.5 | -1.2% | 7,092,700 |
2024/01/23 | 1,715 | 1,734 | 1,714 | 1,724.5 | +14.5 | +0.8% | 6,749,400 |
2024/01/22 | 1,705 | 1,716.5 | 1,698 | 1,710 | ±0 | ±0% | 7,908,000 |
2024/01/19 | 1,710.5 | 1,733 | 1,707.5 | 1,710 | -6.5 | -0.4% | 7,385,400 |
2024/01/18 | 1,744 | 1,758 | 1,715.5 | 1,716.5 | -25 | -1.4% | 9,201,600 |
2024/01/17 | 1,790 | 1,801.5 | 1,741.5 | 1,741.5 | -42 | -2.4% | 10,787,100 |
2024/01/16 | 1,760.5 | 1,786.5 | 1,757.5 | 1,783.5 | +26 | +1.5% | 6,392,700 |
2024/01/15 | 1,755.5 | 1,763 | 1,749 | 1,757.5 | +3.5 | +0.2% | 4,896,900 |
2024/01/12 | 1,800 | 1,800 | 1,747.5 | 1,754 | -10 | -0.6% | 9,901,600 |
2024/01/11 | 1,782 | 1,785 | 1,756 | 1,764 | +1 | +0.1% | 9,077,200 |
2024/01/10 | 1,744 | 1,770.5 | 1,743 | 1,763 | +24.5 | +1.4% | 8,374,600 |
2024/01/09 | 1,726 | 1,756 | 1,721.5 | 1,738.5 | -27.5 | -1.6% | 8,674,400 |
2024/01/05 | 1,762.5 | 1,784.5 | 1,757.5 | 1,766 | +17 | +1% | 8,687,700 |
2024/01/04 | 1,716.5 | 1,749 | 1,701.5 | 1,749 | +63 | +3.7% | 8,582,600 |
2023/12/29 | 1,681.5 | 1,690 | 1,675.5 | 1,686 | +1.5 | +0.1% | 5,307,500 |
2023/12/28 | 1,679 | 1,689.5 | 1,670.5 | 1,684.5 | +7 | +0.4% | 4,803,700 |
2023/12/27 | 1,660 | 1,682 | 1,658 | 1,677.5 | +10 | +0.6% | 6,046,300 |
2023/12/26 | 1,674.5 | 1,679 | 1,659.5 | 1,667.5 | -4 | -0.2% | 3,990,600 |
2023/12/25 | 1,682 | 1,684 | 1,671 | 1,671.5 | +1.5 | +0.1% | 2,450,600 |
2023/12/22 | 1,666 | 1,677.5 | 1,663.5 | 1,670 | +16.5 | +1% | 5,015,000 |
2023/12/21 | 1,662.5 | 1,669.5 | 1,651 | 1,653.5 | -18.5 | -1.1% | 4,806,900 |
2023/12/20 | 1,684 | 1,695.5 | 1,672 | 1,672 | +2.5 | +0.1% | 6,669,500 |
2023/12/19 | 1,640 | 1,671 | 1,635 | 1,669.5 | +37 | +2.3% | 8,025,700 |
2023/12/18 | 1,610 | 1,641 | 1,600.5 | 1,632.5 | +18.5 | +1.1% | 8,116,100 |
2023/12/15 | 1,638.5 | 1,653.5 | 1,608 | 1,614 | -45.5 | -2.7% | 13,883,300 |
2023/12/14 | 1,675 | 1,685 | 1,640.5 | 1,659.5 | -28.5 | -1.7% | 11,143,100 |
2023/12/13 | 1,700.5 | 1,707 | 1,682 | 1,688 | -13.5 | -0.8% | 8,906,000 |
2023/12/12 | 1,740 | 1,749 | 1,701 | 1,701.5 | -28 | -1.6% | 8,542,100 |
2023/12/11 | 1,722.5 | 1,742 | 1,721.5 | 1,729.5 | -15.5 | -0.9% | 7,292,200 |
2023/12/08 | 1,776.5 | 1,778 | 1,745 | 1,745 | -42 | -2.4% | 10,899,300 |
2023/12/07 | 1,805 | 1,806 | 1,782.5 | 1,787 | -22.5 | -1.2% | 6,486,200 |
2023/12/06 | 1,792.5 | 1,813.5 | 1,790 | 1,809.5 | +19 | +1.1% | 5,238,500 |
2023/12/05 | 1,797.5 | 1,797.5 | 1,780.5 | 1,790.5 | -3 | -0.2% | 5,357,400 |
2023/12/04 | 1,800 | 1,801 | 1,777 | 1,793.5 | -13 | -0.7% | 5,674,500 |
2023/12/01 | 1,810 | 1,814 | 1,795.5 | 1,806.5 | +9 | +0.5% | 4,955,600 |
2023/11/30 | 1,787.5 | 1,802 | 1,778 | 1,797.5 | +9.5 | +0.5% | 15,673,200 |
301~
350
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム